Dominant-Negative but not Gain-of-Function Effects of a p53.R270H Mutation in Mouse Epithelium Tissue after DNA Damage
Authors:
- 15 May 2007
- journal article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 67 (10) , 4648-4656
Abstract
p53 alterations in human tumors often involve missense mutations that may confer dominant-negative or gain-of-function properties. Dominant-negative effects result in inactivation of wild-type p53 protein in heterozygous mutant cells and as such in a p53 null phenotype. Gain-of-function effects can directly promote tumor development or metastasis through antiapoptotic mechanisms or transcriptional activation of (onco)genes. Here, we show, using conditional mouse technology, that epithelium-specific heterozygous expression of mutant p53 (i.e., the p53.R270H mutation that is equivalent to the human hotspot R273H) results in an increased incidence of spontaneous and UVB-induced skin tumors. Expression of p53.R270H exerted dominant-negative effects on latency, multiplicity, and progression status of UVB-induced but not spontaneous tumors. Surprisingly, gain-of-function properties of p53.R270H were not detected in skin epithelium. Apparently, dominant-negative and gain-of-function effects of mutant p53 are highly tissue specific and become most manifest upon stabilization of p53 after DNA damage. [Cancer Res 2007;67(10):4648–56]Keywords
All Related Versions
This publication has 42 references indexed in Scilit:
- Probing p53 biological functions through the use of genetically engineered mouse modelsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 2005
- P53 Gain-of-Function: Tumor Biology and Bioinformatics Come TogetherCell Cycle, 2005
- Perp Is a p63-Regulated Gene Essential for Epithelial IntegrityCell, 2005
- p53 Heterozygosity Results in an Increased 2-Acetylaminofluorene-Induced Urinary Bladder but not Liver Tumor Response in DNA Repair-Deficient Xpa MiceCancer Research, 2004
- Lung-specific expression of human mutant p53-273H is associated with a high frequency of lung adenocarcinoma in transgenic miceOncogene, 2002
- Retention of wild‐type p53 in tumors from p53 heterozygous mice: reduction of p53 dosage can promote cancer formationThe EMBO Journal, 1998
- Expression of a p53 mutant in the epidermis of transgenic mice accelerates chemical carcinogenesisOncogene, 1998
- A transgenic mouse model for mammary carcinogenesisOncogene, 1998
- Frequent p53 alterations but low incidence of ras mutations in UV-B-induced skin tumors of hairless miceCarcinogenesis, 1995
- A mutant p53 transgene accelerates tumour development in heterozygous but not nullizygous p53–deficient miceNature Genetics, 1995